发明名称 Method for Predicting the Risk of A Subject For Contracting Diabetes Mellitus And/Or Metabolic Syndrome Or For Diagnosing Metabolic Syndrome In a Subject
摘要 Subject matter of the present invention is a method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject wherein said subject is non-diabetic, comprising the following steps determining the level of pro-neurotensin or fragments thereof of at least 5 amino acids in a bodily fluid obtained from said subject; and correlating said level of pro-neurotensin or fragments thereof with the risk of said subject for contracting diabetes mellitus and/or metabolic syndrome, wherein an elevated level is predictive for an enhanced risk of getting diabetes mellitus and/or metabolic syndrome, or wherein an elevated level correlates to the diagnosis of metabolic syndrome in a subject wherein said subject is non-diabetic.
申请公布号 US2015056203(A1) 申请公布日期 2015.02.26
申请号 US201314383422 申请日期 2013.03.08
申请人 Sphingotec GmbH 发明人 Bergmann Andreas;Melander Olle
分类号 G01N33/68 主分类号 G01N33/68
代理机构 代理人
主权项 1. A method for predicting the risk of getting cancer in a female subject that does not suffer from cancer comprising: determining the level of pro-neurotensin 1-117 or fragments thereof of at least 5 amino acids or pro-neurotensin 1-117 comprising peptides in a bodily fluid obtained from said female subject; and correlating said level of pro-neurotensin 1-117 or fragments thereof or pro-neurotensin 1-117 comprising peptides with the risk of getting cancer, wherein an elevated level is predictive for an enhanced risk of getting cancer and, wherein said cancer is selected from the group comprising breast cancer, lung cancer, pancreatic cancer and colon cancer.
地址 Henningsdorf DE